z-logo
open-access-imgOpen Access
EVOLUTION OF DRUG THERAPY FOR LUNG CANCER WITH EGFR INHIBITORS: NEW ASPECTS
Author(s) -
M. Stepanova,
L.V. Khalicova,
А. С. Жабина,
Fedor Moiseenko
Publication year - 2019
Publication title -
practical oncology
Language(s) - English
Resource type - Journals
eISSN - 1726-9830
pISSN - 1726-9814
DOI - 10.31917/2001052
Subject(s) - lung cancer , medicine , drug , pharmacotherapy , cancer therapy , erlotinib , oncology , cancer , pharmacology , intensive care medicine , epidermal growth factor receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom